Development, Preclinical Evaluation and Preliminary Dosimetry Profiling of SB03178, a First-of-its-kind Benzo[h]quinoline-Based Fibroblast Activation Protein-Α-targeted Radiotheranostic for Cancer Imaging and Therapy.